Easy Bruising is Not a Recognized Side Effect of Vyvanse
Easy bruising is not listed as a known adverse reaction to Vyvanse (lisdexamfetamine) in the FDA drug label or clinical trial data. If you are experiencing easy bruising after starting Vyvanse 30 mg daily, this warrants further evaluation for alternative causes rather than attributing it directly to the medication.
What the Evidence Shows
The FDA drug label for Vyvanse 11 provides comprehensive adverse reaction data from controlled clinical trials. The most common adverse reactions (≥5% incidence and at least twice placebo rate) in adults include:
- Decreased appetite (27%)
- Insomnia (27%)
- Dry mouth (26%)
- Diarrhea (7%)
- Nausea (7%)
- Anxiety (6%)
- Increased blood pressure and heart rate
- Weight loss
- Headache
Bruising, petechiae, or bleeding complications are notably absent from these adverse reaction tables 11.
The One Vascular Concern to Know About
While bruising itself isn't reported, Vyvanse does carry a warning for peripheral vasculopathy, including Raynaud's phenomenon 1. This involves vasospastic events affecting blood flow to extremities, but this manifests as:
- Digital ulceration
- Color changes in fingers/toes
- Pain in extremities
- Not typically easy bruising
There is one case report of a branch retinal artery occlusion potentially associated with lisdexamfetamine-induced vasospasm 2, but this represents an extremely rare vascular event, not a bleeding or bruising disorder.
What You Should Actually Investigate
If easy bruising has developed since starting Vyvanse, consider these more likely explanations:
Medication interactions: Check if you're taking any antiplatelet agents, NSAIDs, SSRIs, or anticoagulants that could interact or have additive effects.
Platelet or coagulation disorders: Obtain a complete blood count with platelet count, PT/INR, and PTT to rule out thrombocytopenia or coagulation abnormalities.
Nutritional deficiencies: Vyvanse commonly causes decreased appetite and weight loss 11. Significant dietary changes could lead to vitamin C or K deficiency, which can cause easy bruising.
Unrelated concurrent illness: The timing may be coincidental with another process (viral illness, autoimmune condition, etc.).
Clinical Bottom Line
The temporal association between starting Vyvanse and developing easy bruising does not establish causation, especially when this adverse effect is not documented in extensive clinical trial data 1134. The most prudent approach is to:
- Continue Vyvanse if it's providing therapeutic benefit for ADHD
- Obtain basic laboratory work (CBC with platelets, coagulation studies)
- Review all medications for potential interactions
- Assess nutritional intake given Vyvanse's appetite-suppressing effects
- Monitor closely - if bruising worsens or other bleeding manifestations develop, reassess
The extensive safety data from multiple clinical trials in both pediatric and adult populations 345 does not support easy bruising as a medication-related adverse effect of lisdexamfetamine.